NEW YORK (Reuters) – Moderna Inc said on Tuesday that it plans to start late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Moderna said it will conduct the trial at 87 study locations, all in the U.S.
(Reporting by Michael Erman, Editing by Franklin Paul)
